EMARETAMIG
UNII 8P2N8N28WN

Substance Identification & Data

This profile provides standardized clinical and technical data for Emaretamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8P2N8N28WN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3051701-97-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8P2N8N28WN
CAS Registry Number
3051701-97-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EMARETAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C187658
National Cancer Institute reference terminology for clinical and research data.
INN ID
13773
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emaretamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ANTI-CLDN18.2/ANTI-CD3 BISPECIFIC ANTIBODY ASP2138
ASP 2138 [WHO-DD]
CLAUDIN18.2 X CD3 BISPECIFIC ANTIBODY ASP2138
EMARETAMIG
EMARETAMIG [INN]
IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_(G1(VH-CH1-H)-10MER-SCFVLH-10MER-G1(H-CH2-CH3)_L-KAPPA), ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), ONOCLONAL ANTIBODY, BISPECIFIC, TRIVALENT (EMARETAMIG)
IMMUNOGLOBULIN G1 (507-PROLINE,508-VALINE,509-ALANINE,DEL-510-GLYCINE,541-LYSINE,631-GLUTAMINE,638-LYSINE), BISPECIFIC, ANTI-(HUMAN CLAUDIN-18.2) (HUMAN-MUS MUSCULUS MONOCLONAL ASP2138 VH-CH1 FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL ASP2138 SINGLE-CHAIN VARIABLE FRAGMENT VL-(GKPGS)4-VH) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH HUMAN-MUS MUSCULUS MONOCLONAL ASP2138 .GAMMA.1-CHAIN HINGE-CH2-CH3 FRAGMENT, (500->227') (503->230')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (209'-ASPARTIC ACID,234'-PROLINE,235'-VALINE,236'-ALANINE,DEL-237'-GLYCINE,268'-LYSINE,296'-GLUTAMIC ACID,369'-ASPARTIC ACID,371'-SERINE,385'-ASPARTIC ACID,419'-GLUTAMIC ACID,422'-ASPARTIC ACID) ANTI-(HUMAN CLAUDIN-18.2) (HUMAN-MUS MUSCULUS MONOCLONAL ASP2138 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ASP2138 .KAPPA.-CHAIN

Technical Codes

ASP-2138

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus